Biobank: UK health data of 500,000 people for sale in China

• UK Biobank data on 500,000 participants has been identified for sale on Alibaba, raising serious concerns about data security, patient consent breach, and regulatory compliance with UK data protection laws.
• This incident highlights critical vulnerabilities in health data governance and the need for clinicians to understand data protection obligations when contributing to or recommending patients for biobank participation.
• Practitioners should be aware of potential reputational and legal implications for institutions involved in biobanks, and should counsel patients on data security risks when discussing participation in health research initiatives.

The data of hundreds of thousands of people who participated in the UK's health data project was for sale on the website Alibaba.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.